CLINIGMA ApS: Financial statements 2019
CVR: 39350580
CLINIGMA ApS (CVR 39350580) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 1,095,538 and a net result of DKK 899 compared with DKK 10,870 the year before. The profit margin was 0.1%. Equity amounted to DKK 561,769. The solvency ratio was 76.7%. The company had 2 employees in the financial year.
- Revenue
- 1,095,538 kr.
- Gross Profit
- 348,708 kr.
- Profit/Loss
- 899 kr.
- Equity
- 561,769 kr.
- Total Assets
- 732,196 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 1.1 mio. | 349 t. | 899 | 562 t. | 2 |
| 2018 | - | 62 t. | 11 t. | 61 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
CLINIGMA ApS has published its interim report for the period February 15, 2018 – December 31, 2018.
About CLINIGMA ApS
CLINIGMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2018. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Clinical Survey Outcomes ApS. The management consists of Christian Bredmose Holm. The company is owned by Kongsø Gruppen ApS and CH Technologies Holding ApS. In 2025, the company reported a gross profit of DKK 7,829,455 and a net result of DKK 2,200,115 compared with DKK -133,939 the year before. Equity amounted to DKK 69.
